Tag Archives: Cipla to sell Baricitinib to treat COVID-19 patients in India after tying up with Eli Lilly

Cipla to sell Baricitinib to treat COVID-19 patients in India after tying up with Eli Lilly

Baricitinib, which is used along with the Remdesivir to treat the  Covid-19 patients, received an approval from the health ministry’s CDSCO for restricted emergency use only. As the pandemic situation of Covid-19 is increasing continuously in India, the medical infrastructure of India has collapsed and India is now facing a huge shortage of essential medicines, […]